(Q38223007)

31 August 2017

Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective (English)

1 reference

31 August 2017

Nadejda M Tsankova

1

1 reference

31 August 2017

Peter Canoll

series ordinal

2

1 reference

31 August 2017

language of work or name

1 reference

25 June 2014

1 reference

Journal of Neuro-Oncology

31 August 2017

1 reference

31 August 2017

119

1 reference

31 August 2017

3

1 reference

31 August 2017

481-490

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-014-1499-x

31 August 2017

0 references

cites work

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Molecular markers in gliomas: impact for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Epidermal growth factor receptor as a therapeutic target in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

IDH mutation impairs histone demethylation and results in a block to cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Molecular neuro-oncology in clinical practice: a new horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Histone H3.3 mutations: a variant path to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Transforming fusions of FGFR and TACC genes in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The integrated landscape of driver genomic alterations in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The cellular origin for malignant glioma and prospects for clinical advancements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The transcriptional network for mesenchymal transformation of brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Neural stem cells and the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Malignant glioma: lessons from genomics, mouse models, and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The interface between glial progenitors and gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The epigenetic progenitor origin of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Cancer epigenetics: linking basic biology to clinical medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The DNA methylome of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Expression of EGFRvIII in glioblastoma: prognostic significance revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1499-X

10.1007/S11060-014-1499-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference